Global Medical Response, operating under the name GMR Solutions, announced a sharp downward revision to the valuation it is seeking in its pending U.S. initial public offering, cutting the target to roughly $3.3 billion from a prior $5 billion goal. The adjustment comes as the company reduced both the planned offering size and the proposed share price in response to tepid investor demand.
The Lewisville, Texas-based emergency medical services provider is marketing 31.9 million shares at $15 each, which would raise about $478.7 million. That compares with its earlier plan to offer shares at a $22 to $25 range and to raise up to $797.9 million. The company is expected to complete pricing for the IPO later on Tuesday.
Analysts and market observers have noted that while the IPO market has shown signs of revival since a brief lull in March, interest remains uneven and selective. Matt Kennedy, senior strategist at Renaissance Capital, said the cut in price is an indication that the recent pickup in IPO activity is fragile. In his view, investors are willing to allocate capital to the hottest new listings but are bypassing companies with less compelling stories.
"Today’s price cut signals that the recent IPO pick-up is still somewhat precarious. Investors are anxious to participate in hot IPOs, but content to pass over the less-exciting stories," Kennedy said.
Kennedy also cited GMR’s debt burden and its relatively slow growth as factors behind the subdued investor reception to date. The company completed a $5.4 billion refinancing in 2025 and, as of December 31, carried roughly $5 billion in long-term debt. The prominence of debt on the balance sheet has forced sponsors to reduce equity value in order to meaningfully affect enterprise valuation, a dynamic Kennedy said could benefit investors only if the company executes and deleverages over time.
GMR is a major provider of essential emergency medical services, operating across approximately 1,400 U.S. counties. For the quarter ended March 31, the company expects revenue between $1.42 billion and $1.46 billion, up from $1.37 billion a year earlier.
Investment funds affiliated with KKR, Ares and HPS are expected to increase their private purchase of warrants tied to the offering, now projected at $500 million, up from an earlier plan to acquire $350 million. J.P. Morgan, KKR and BofA Securities are listed among the underwriters for the IPO.
This adjustment in valuation and offering size underscores the selective appetite among investors for new listings right now, particularly for companies where leverage and growth trajectories present questions about near-term equity returns.